Skip to content

Development and Application of the COPD Medication Assistant

Development and Application of the COPD Medication Assistant

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129454
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-08-08
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Intervention group:AI interactive scenario guidance and exclusive visual animation intervention

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age is 18 years or above; 2. Diagnosed by a doctor and clinically confirmed as chronic obstructive pulmonary disease; 3. Voluntarily participate in this clinical study and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1.It is impossible to obtain the informed consent from the patients or their families. 2.The doctor has determined that there are cognitive and mental functional impairments, severe visual, auditory and communication disorders, as well as other conditions that affect the use of inhalation devices. 3.The pharmacist determined that the research subjects were unable to comply with the trial plan for other reasons.

Design outcomes

Primary

MeasureTime frame
AI Usage Selectivity Score in Low/High-Risk Scenarios;

Secondary

MeasureTime frame
Chronic Obstructive Pulmonary Disease Knowledge Questionnaire;Willingness to use mobile AI assistants in low-risk scenarios;

Countries

China

Contacts

Public ContactLihong Liu

China-Japan Friendship Hospital

hongllh@126.com+86 10 84205559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026